Home

Üzletember Esik tegnap vodicska barbara a levél Elhanyagolás strand

Istvan Petak, MD, PhD on LinkedIn: #digitalhealth #ai #health  #artificialintelligence #precisiononcology…
Istvan Petak, MD, PhD on LinkedIn: #digitalhealth #ai #health #artificialintelligence #precisiononcology…

Deutsches Krebsforschungszentrum
Deutsches Krebsforschungszentrum

Editorial Board - Current Problems in Cancer: Case Reports - Journal -  Elsevier
Editorial Board - Current Problems in Cancer: Case Reports - Journal - Elsevier

Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research  profile
Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research profile

Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research  profile
Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research profile

Tweets with replies by EUNIC Brussels (@EUNIC_Brussels) / Twitter
Tweets with replies by EUNIC Brussels (@EUNIC_Brussels) / Twitter

AI For Good meetup
AI For Good meetup

A computational method for prioritizing targeted therapies in precision  oncology: performance analysis in the SHIVA01 trial | npj Precision Oncology
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial | npj Precision Oncology

Hungarian Cultural Center Brussels | Dr. Barbara Vodicska at the Future of  Living Conference 2022 at Bozar
Hungarian Cultural Center Brussels | Dr. Barbara Vodicska at the Future of Living Conference 2022 at Bozar

Artificial Intelligence, Art and our Society: The Future of Living  conference bore a strong Czech footprint in Brussels
Artificial Intelligence, Art and our Society: The Future of Living conference bore a strong Czech footprint in Brussels

Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research  profile
Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research profile

Diagnostics | Free Full-Text | Personalized First-Line Treatment of  Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy  and Computational Decision Support
Diagnostics | Free Full-Text | Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

Sotillo Lab
Sotillo Lab

karusszellovasudvar - G-Portál
karusszellovasudvar - G-Portál

Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research  profile
Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research profile

JPM | Free Full-Text | Efficacy of Incremental Next-Generation ALK  Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC
JPM | Free Full-Text | Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC

FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for  degradation.,Cell Death and Differentiation - X-MOL
FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.,Cell Death and Differentiation - X-MOL

personalized treatment — Research News — ALK POSITIVE
personalized treatment — Research News — ALK POSITIVE

AI For Good meetup
AI For Good meetup

DAVID GENTIEN | Institut Curie
DAVID GENTIEN | Institut Curie

VODICSKA BARBARA név elemzése
VODICSKA BARBARA név elemzése

VODICSKA BARBARA név elemzése
VODICSKA BARBARA név elemzése

TUDOMÁNYOS DIÁKKÖRI KONFERENCIA - PDF Ingyenes letöltés
TUDOMÁNYOS DIÁKKÖRI KONFERENCIA - PDF Ingyenes letöltés

Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research  profile
Barbara VODICSKA | Lead Scientist | Doctor of Philosophy | R&D | Research profile

Oncompass Medicine
Oncompass Medicine

FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for  degradation | bioRxiv
FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation | bioRxiv